Denka Company Limited(4061) News

Notice Regarding Results of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)

Announcement of Extraordinary Gains (Gain on Sale of Investment Securities)

Notice Concerning Change in Equity-Method Affiliate (Becoming a Consolidated Subsidiary)

(Amendment) Notice Regarding Amendment to “Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc.”

Feb 27, 2026 Management Presentation Management Plan Mission 2030 Phase 2 (FY2026～FY2028)

Notice of Commencement of Consideration of Spin-off of Styrene-Related Businesses

Notice of Formulation of Management Plan “Mission 2030” Phase 2 (FY2026～FY2028)

[Delayed]Notice Regarding Commencement of Tender Offer for Share Certificates, Etc. of KAINOS Laboratories, Inc. (Securities Code: 4556)

Notice Regarding Recognition of Extraordinary Losses

Notice Regarding Personnel Changes in Executive Officers

Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2026 (Under Japanese GAAP)

Results Presentation of FY2025 3Q

Denka Company, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 3.2 times, Oct-Dec Ordinary Profit Turns to Profit

Notice Regarding Recognition of Extraordinary Losses

Results Presentation of FY2025 2Q (Financial Results and Topic: Direction of Management Plan Mission 2030 Revision)

Denka Company, First Half Ordinary Profit Unexpectedly Revised Upward by 22%

Consolidated Financial Results for the First Six Months of the Fiscal Year Ending March 31, 2026 (Under Japanese GAAP)

Notice on Difference Between Consolidated Financial Results Forecast for the First Half of the Fiscal Year Ending March 31, 2026 and Actual Results

[Delayed]Corporate Governance Report

Denka Company, Apr-Jun (1Q) Ordinary Profit Decreases by 54%